Benjamin Graham fit · Inversión deep-value defensiva
Is Acadia Pharmaceuticals Inc. (ACAD) a Benjamin Graham Stock?
Meets 2/7 Graham criteria — partially qualifies.
56/100
CSeñales mixtas
2/7 criterios cumplidos
Los criterios de Benjamin Graham, aplicados a ACAD
P/E ≤ 15
clave—
P/B ≤ 1.5
clave11.7x
Current ratio ≥ 2
3.0x
Debt / Equity ≤ 1
0.0x
Cómo se valora ACAD en otras estrategias
Datos financieros en vivo
Cap. mercado
$4.65B
PER (TTM)
19.0x
ROIC (TTM)
25.22%
Margen bruto
91.92%
Preguntas frecuentes
What is ACAD's Benjamin Graham fit score?
ACAD scores 56/100 on our Benjamin Graham fit engine — grade C. Meets 2/7 Graham criteria — partially qualifies.
Does Benjamin Graham actually own ACAD?
Our score is computed from financial fundamentals against Benjamin Graham's published criteria. We don't claim that Benjamin Graham personally owns or recommends ACAD.
How often is this score updated?
ACAD's Benjamin Graham fit score is recomputed daily from the latest TTM financials.
Herramienta educativa, no es asesoramiento financiero. Las puntuaciones se calculan a partir de datos financieros públicos contra los criterios publicados de cada estrategia de inversión. No afirmamos que Benjamin Graham posea o recomiende ACAD personalmente.